Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis

View source ↗

Summary

A clinical trial update indicates the study of nalfurafine hydrochloride for pruritus in primary biliary cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalfurafine hydrochloride (nalfurafine hydrochloride)

Snippet

Sponsor: Teikyo University | Conditions: Primary Biliary Cirrhosis | Status: COMPLETED